14.04.2023 • NewsGevoLG ChemBiofuels

Gevo and LG Chem Partner on Bio-propylene

US renewable chemicals and advanced biofuels company Gevo has entered into a joint development agreement for its ethanol-to-olefins (ETO) technology with South Korean chemicals group LG Chem.

Under the terms of the deal, the companies will collaborate to accelerate the pilot research, technical scale-up and commercialization of bio-propylene using Gevo’s ETO technology for use in renewable chemicals.

Gevo said its proprietary technology can target carbon neutral or carbon negative drop-in replacements for traditional petroleum-based building blocks such as propylene. The plant-based renewable olefin will be derived from atmospheric CO2 captured through photosynthesis and is expected to deliver the same performance in the final product as its fossil-based counterpart.

“We believe Gevo’s ethanol-to-olefin’s process can be more capital and energy efficient than existing technologies to make the renewable olefin intermediates used in the production of chemicals or fuels,” said Gevo’s chief carbon and innovation officer Paul Bloom.

“Our partnership with LG Chem is a great example of how we intend to accelerate development and commercialization of our ETO technology to enable renewable chemicals with our world-class partner while Gevo plans to deploy the technology to lower the cost and carbon intensity for sustainable aviation fuel and other drop-in fuels like renewable diesel.”

Gevo said it expects the bio-propylene could play a pivotal role in the rapid growth of the bioplastic market and circular economy. Once commercialization is achieved, the renewable olefin could also be used as a drop-in replacement for petroleum-based materials in products for automobile interiors and exteriors, flooring and diapers.

Author: Elaine Burridge, Freelance Journalist

© Shutterstock/Corona Borealis Studio
© Shutterstock/Corona Borealis Studio

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.